Subscriptions: Information about subscribing to Hypertension is online at
|
|
- Joleen Bradford
- 6 years ago
- Views:
Transcription
1 Inflammation, Abdominal Obesity, and Smoking as Predictors of Hypertension Leo Niskanen, David E. Laaksonen, Kristiina Nyyssönen, Kari Punnonen, Veli-Pekka Valkonen, Ricardo Fuentes, Tomi-Pekka Tuomainen, Riitta Salonen and Jukka T. Salonen Hypertension 2004;44; ; originally published online Oct 18, 2004; DOI: /01.HYP Hypertension is published by the American Heart Association Greenville Avenue, Dallas, TX Copyright 2004 American Heart Association. All rights reserved. Print ISSN: X. Online ISSN: The online version of this article, along with updated information and services, is located on the World Wide Web at: Subscriptions: Information about subscribing to Hypertension is online at Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, 351 West Camden Street, Baltimore, MD Phone Fax: Reprints: Information about reprints can be found online at Downloaded from hyper.ahajournals.org by on April 25, 2006
2 Inflammation, Abdominal Obesity, and Smoking as Predictors of Hypertension Leo Niskanen, David E. Laaksonen, Kristiina Nyyssönen, Kari Punnonen, Veli-Pekka Valkonen, Ricardo Fuentes, Tomi-Pekka Tuomainen, Riitta Salonen, Jukka T. Salonen Abstract Development of hypertension has been linked to chronic low-grade inflammation. However, it is not known whether this connection is mediated by features of the metabolic syndrome or smoking, or their changes, which themselves have been linked to inflammation. We studied the predictive value of highly sensitive C-reactive protein (hs-crp), smoking, and abdominal obesity to the development of hypertension in an 11-year follow-up of a population-based study cohort comprising 379 middle-aged normotensive men. During the follow-up, 124 men (33%) developed hypertension. Men with hs-crp 3.0 mg/l were 2.8 (95% confidence interval, 1.2 to 6.6) more likely to develop hypertension than with hs-crp 1.0 mg/l even after adjustment for features of the metabolic syndrome, lifestyle factors, and their changes. Cigarette smoking was also associated with development of hypertension independently of inflammation and other confounders. Waist girth increased more in men who quit smoking than in other men. An increase in waist girth during follow-up strongly predicted incident hypertension. The decrease in smoking was not associated with a lower risk of hypertension in age-adjusted analyses. Hypertension is preceded by low-grade chronic inflammation in middle-aged white men independently of smoking or features of the metabolic syndrome. Furthermore, smoking may be a risk factor for hypertension. Although stopping smoking is beneficial with respect to health outcomes, the subsequent increase in weight and waist girth associated with smoking cessation may offset the decrease in the risk of hypertension that one may otherwise expect. (Hypertension. 2004;44: ) Key Words: obesity smoking prospective studies insulin resistance Chronic low-grade inflammation seems to be an early feature of many chronic degenerative disorders, including atherosclerosis, abdominal obesity, and type 2 diabetes. 1 3 These disorders are also commonly associated with hypertension, which itself has also been linked recently to inflammation. The most compelling evidence comes from the Women s Health Study, in which C-reactive protein (CRP) as a marker of low-grade inflammation predicted the development of hypertension in a cohort of female US health professionals during a follow-up of 7.8 years. 4 This effect was seen even in those with low baseline blood pressure levels and in those without other conventional cardiovascular risk factors, but no adjustment could be made for the presence of the metabolic syndrome, a possible mediator of this connection. 5 Smoking causes an acute rise in blood pressure, whereas the connection between chronic smoking and development of hypertension is still unclear. Smoking in its own right increases inflammation, 6 but smoking cessation may not reverse it. 7 Furthermore, stopping smoking commonly leads to weight gain. Weight gain is a well-established risk factor for hypertension. Moreover, weight gain and obesity, especially abdominal, appear to not only cause inflammation but may be preceded by inflammation. 8 Complicating the picture, increased alcohol intake is associated with hypertension and smoking but possibly decreased abdominal fat. 9 Observational studies are hampered with problems when describing these intertwined phenomena. If we are to understand chronic low-grade inflammatory processes in relation to the multifactorial origin of hypertension, the ideal study setting should describe various pathways leading to hypertension by taking into account the changes in these factors. In this study, we assessed the predictive value of low-grade inflammation in the development of hypertension in middleaged men during an 11-year follow-up, controlling for baseline blood pressure, various lifestyle factors, features of metabolic syndrome, and also the changes in smoking, alcohol intake, and waist girth during follow-up. Furthermore, we evaluate the role of smoking independently of inflammation and changes in waist girth with the development of hypertension. Received July 1, 2004; first decision July 22, 2004; revision accepted September 22, From the Departments of Medicine (L.N., D.E.L.) and Clinical Chemistry (K.P.), Kuopio University Hospital, Finland; Research Institute of Public Health (K.N., V-P.V., T-P.T., J.T.S.) and Department of Public Health and General Practice (R.S.), University of Kuopio, Finland; and Jurilab Ltd (R.F., J.T.S.), Kuopio, Finland. Reprint requests to Kristiina Nyyssönen, PhD, Research Institute of Public Health, University of Kuopio, PO Box 1627, FIN Kuopio, Finland. Kristiina.Nyyssonen@uku.fi 2004 American Heart Association, Inc. Hypertension is available at DOI: /01.HYP
3 860 Hypertension December 2004 Methods Participants Subjects were participants of the Kuopio Ischemic Heart Disease Risk Factor Study. 10 Participants were a random age-stratified sample of men living in Eastern Finland who were 42, 48, 54, or 60 years old at the baseline examination from 1987 to The recruitment and study design have been described previously in detail. 10 Repeat examinations for those who had undergone carotid ultrasound at baseline were performed from 1991 to 1994 (4-year follow-up) and 1998 to 2001 (11-year follow-up). In all, 854 men participated in the 11-year follow-up (90% of those alive). Men with hypertension or diabetes at baseline were excluded, leaving 379 men for analyses of incident hypertension during the 11-year follow-up. The university ethics committee approved the study. All participants gave their written informed consent. Definition of Hypertension Blood pressure was measured with a random-zero mercury sphygmomanometer (Hawksley and Sons). The protocol included 3 measurements while supine, 1 while standing, and 2 while sitting, with 5-minute intervals between measurements. The mean of the 2 sitting measurements was used as the systolic and diastolic blood pressure. Hypertension was defined at baseline and follow-up as systolic blood pressure 140 mm Hg, diastolic blood pressure 90 mm Hg, or use of antihypertensive medication. 11,12 Anthropometric and Biochemical Measurements Body mass index (BMI) was computed as the ratio of weight to the square of height (kg/m 2 ). Waist circumference was defined as the average of 2 measurements taken at the midpoint between the lowest rib and the iliac crest after inspiration and expiration. Fasting blood glucose was measured using a glucose dehydrogenase method after precipitation of proteins by trichloroacetic acid. Diabetes was defined as fasting blood glucose concentration 6.1 mmol/l (equivalent to plasma glucose 7.0 mmol/l) or a clinical diagnosis of diabetes with dietary, oral, or insulin treatment. 13 Serum insulin was determined with a Novo Biolabs radioimmunoassay kit (Novo Nordisk). HDL fractions were separated from fresh serum by combined ultracentrifugation and precipitation. The cholesterol contents of lipoprotein fractions and serum triglycerides were measured enzymatically. Fibrinogen was measured based on the clotting of diluted plasma with excess thrombin. Measurement of Highly Sensitive CRP Serum CRP was measured with an immunometric assay (Immulite High Sensitivity CR Assay; DPC). 14 We used CRP cut-offs of 1.0 mg/l and 3.0 mg/l, as recommended by the Center for Disease Control and the American Heart Association. 15 To limit confounding with acute infection or occult disease, we excluded men with CRP concentrations 10.0 mg/l. Other Assessments Assessments of medical history and medications, smoking, alcohol consumption, adult socioeconomic status, and moderate-to-vigorous leisure-time physical activity have been described previously. 16,17 Dietary intake of saturated fat, sodium, potassium, and fruits and vegetables was measured with 4-day food records as grams per day and adjusted by regression analysis for energy intake. 18 Highresolution B-mode ultrasonography was used to examine a 1.0- to 1.5-cm section at the distal end of the left and right common carotid artery proximal to the carotid bulb, as explained in detail previously. 19 Statistical Analyses Differences in baseline characteristics between men who developed hypertension and those who did not were assessed with Student t test, and where indicated, the 2 test. Fibrinogen is an acute phase reactant and as such, a marker of inflammation that has a high correlation with CRP levels (r 0.50). To avoid problems with multicollinearity, we adjusted fibrinogen by CRP using linear regression before including it in the logistical regression models. To investigate the associations of CRP concentrations with hypertension, CRP concentrations were categorized using the cut-offs 1.0 mg/l, 1.0 to 2.9 mg/l, and 3.0 to 9.9 mg/l. 15 Cigarette smoking was categorized as not at all, 1 to 19 cigarettes per day, and 20 cigarettes per day. Alcohol intake was converted into grams of ethanol per week and classified as none at all, 1 to 83 g per week, and 84 g per week (84 g of ethanol is 7 drinks). Waist circumference was categorized into thirds (only 17% and 3% of nonhypertensive men had waist girths 94 and 102 cm, values that have been recommended as action levels for prevention of chronic disease). 20 The variables in question were entered into logistic regression models adjusting for age and potential mediating or confounding variables. The association of changes in waist circumference, smoking (as cigarettes per day), and alcohol intake with incident hypertension were similarly analyzed as continuous variables in logistic regression models. The covariates for the logistic regression models were forced into the model. Variables are given as means SD, except for variables with a skewed distribution (CRP, insulin, triglycerides, alcohol intake, and physical activity), which are given as medians and interquartile ranges, and proportions, which are given as percentages. In analyses using continuous variables, skewed variables were log transformed. The mean was substituted for missing values (n 10 to 23) of covariates. Statistical significance was considered to be P All statistical analyses were performed with SPSS 11.0 for Windows. Results Baseline Clinical Characteristics During the 11-year follow-up, men who developed hypertension were heavier, had a larger waist, and were more dyslipidemic at baseline (Table 1). They also had higher blood pressure. The prevalence of the metabolic syndrome was uncommon in these relatively lean men without hypertension or diabetes but was more common in those who developed hypertension during the follow-up. Smokers more commonly developed hypertension, but the change in the number of cigarettes smoked did not differ between men who developed and did not develop hypertension. Alcohol intake was similar in both groups, but increased alcohol intake at the 4-year follow-up was more common in men who developed hypertension by the 11-year follow-up. Baseline CRP concentrations were much higher in men who later developed hypertension. CRP at Baseline and Hypertension Men with CRP concentrations 3 mg/l were 3.6 more likely to develop hypertension than men with levels 1.0 mg/l in age-adjusted analyses (Table 2). Adjustment for baseline blood pressure, lifestyle factors, and cardiovascular disease (model 2) only marginally weakened the association. After additional adjustment for features of the metabolic syndrome at baseline (model 3) or further for changes in waist circumference, number of cigarettes smoked per day, or intake of alcohol (model 4) during the first 11 years of follow-up, men with CRP levels 3 mg/l were still 2.8 more likely to develop hypertension during the 11-year follow-up. Adjustment for changes in waist girth, smoking, or alcohol intake over the 4-year period gave similar results as in model 4. Adjustment for development of cardiovascular disease during follow-up also had little effect on the results. Inclusion of BMI in models 2 through 4 in place of or in
4 Niskanen et al CRP, Smoking, and Hypertension 861 TABLE 1. Baseline Characteristics of Men Who Developed Hypertension During Follow-Up and Those Who Did Not Descriptive Variables Nonhypertensive at Follow-Up Hypertensive at Follow-Up P N Age (years) 50.2 (6.6) 51.8 (6.7) Smokers (%) Change in smoking during follow-up (for smokers) At 4 years (n 133), cigarettes per day 3 (11) 4 (9) 0.88 At 11 years (n 132), cigarettes per day 8 (15) 4 (13) 0.14 Alcohol consumption, g/week 31 (6, 87) 28 (7, 89) 0.83 Change in alcohol intake during follow-up (for nonabstainers) At 4 years (n 314), g/week 5 (119) 22 (74) At 11 years (n 346), g/week 4 (150) 25 (112) 0.19 Cardiovascular disease, % Maximum carotid intima thickness, mm 0.88 (0.78, 0.98) 0.91 (0.80, 1.05) Adult socioeconomic status score 6.9 (3.9) 6.8 (4.0) 0.73 Systolic blood pressure, mm Hg 121 (9) 128 (8) Diastolic blood pressure, mm Hg 79 (6) 84 (6) Body mass index, kg/m (2.7) 26.1 (2.9) Waist circumference, cm 85.3 (7.9) 88.3 (8.0) Change in waist girth during follow-up At 4 years 4.4 (4.1) 5.3 (3.9) At 11 years 7.1 (5.8) 8.7 (5.9) Serum LDL cholesterol, mmol/l 3.8 (0.9) 4.0 (1.1) Serum HDL cholesterol, mmol /L 1.40 (0.29) 1.28 (0.26) Serum triglycerides, mmol/l 0.96 (0.75, 1.38) 1.10 (0.83, 1.64) Fasting blood glucose, mmol /L 4.48 (0.45) 4.52 (0.47) 0.42 Fasting serum insulin, pmol/l 7.9 (6.2, 10.3) 8.9 (7.0, 11.2) Fibrinogen (g/l, unadjusted) 2.81 (0.50) 3.02 (0.50) Metabolic syndrome (NCEP), % Moderate and vigorous LTPA, min/week 143 (62, 256) 128 (56, 241) 0.24 Serum CRP, g/dl 0.81 (0.50, 1.46) 1.24 (0.76, 2.33) Values are means (SD), medians (interquartile ranges), or percentages. Higher adult socioeconomic status score means lower socioeconomic status. NCEP indicates National Cholesterol Education Program 29,30 ; LTPA, leisure-time physical activity. addition to waist girth had little effect on the results. CRPadjusted fibrinogen was not associated with incident hypertension, and inclusion of CRP-adjusted fibrinogen in the models did not affect the association of CRP with incident hypertension. The risk associated with CRP levels was graded, and men with levels between 1.0 and 3.0 mg/l were also at increased risk for developing hypertension. CRP concentrations also predicted incident hypertension at 11 years even after adjustment for the average maximum thickness of the intima carotid for the left and right carotid arteries in addition to technical covarates (odds ratio [OR] for CRP, 3 mg/l versus 1 mg/l 2.4 to 2.9 in models 2 to 4; P to for the trend). CRP levels 3.0 mg/l were quite uncommon (n 39) in these relatively lean men without hypertension or diabetes at baseline, but the results were very similar when using tertiles to categorize CRP (data not shown). CRP concentrations also predicted use of blood pressure medication at 11 years (OR for CRP, 3 mg/l versus 1 mg/l 3.1 to 3.5 in all models; P to for the trend) and incident hypertension when defining hypertension at the 11-year follow-up solely by systolic and diastolic blood pressure rather than including medication in the definition (data not shown). There was no evidence of modification of the association of CRP with hypertension after stratification by median systolic blood pressure, BMI, or smoking status. Smoking at Baseline and Hypertension Men who smoked 20 cigarettes per day were more than twice as likely to develop hypertension (Table 2). Additional adjustment for features of the metabolic syndrome at baseline (model 3) weakened the association. However, after taking
5 862 Hypertension December 2004 TABLE 2. ORs (95% CI) of Developing Hypertension During the 11-Year Follow-Up According to CRP Concentrations, Smoking, Alcohol Intake, and Waist Circumference, Respectively Predictive Variable Model 1 Model 2 Model 3 Model 4 CRP concentrations* mg/l (n 210) 1 (reference) mg/l (n 130) 1.82 ( ) 1.83 ( ) 1.66 ( ) 1.78 ( ) mg/l (n 39) 3.55 ( ) 3.31 ( ) 2.87 ( ) 2.81 ( ) P for trend Cigarettes per day 0(n 260) 1 (reference) (n 41) 1.57 ( ) 1.83 ( ) 1.76 ( ) 2.50 ( ) 20 (n 77) 2.38 ( ) 2.37 ( ) 1.95 ( ) 3.37 ( ) P for trend Alcohol, g/week 0(n 49) 1 (reference) (n 232) 1.25 ( ) 0.89 ( ) 0.90 ( ) 0.91 ( ) 84 (n 98) 1.46 ( ) 0.84 ( ) 0.94 ( ) 0.92 ( ) P for trend Waist girth at baseline 82.5 cm (n 127) 1 (reference) cm (n 121) 2.23 ( ) 1.96 ( ) 1.43 ( ) 1.57 ( ) 88.5 (n 131) 2.32 ( ) 1.83 ( ) 1.10 ( ) 1.29 ( ) P for trend *Model 1, Age-adjusted; model 2, adjusted for age, smoking (none, 1 19, and 20 cigarettes per day), alcohol intake (abstinent, 1 83 g, and 84 g ethanol per week), adult socioeconomic status, leisure-time physical activity, presence of cardiovascular disease, intake of energy-adjusted dietary factors (dietary intake of saturated fat, sodium, potassium, and fruits and vegetables), and baseline systolic blood pressure; model 3, adjusted for variables in model 2 and waist girth ( 82.5 cm, cm, and 88.5 cm), and concentrations of insulin, glucose, and HDL cholesterol; model 4, adjusted for variables in model 3 and changes in waist girth, smoking (cigarettes per day), and alcohol intake (g/day) during the 11-year period. Models as above, except that CRP categories were used as a covariate in place of smoking in models 2 4. Models as above, except that CRP categories were used as a covariate in place of alcohol intake in models 2 4. Models as above, except that CRP categories were used as a covariate in place of waist girth in models 3 4. into account the changes in waist circumference, number of cigarettes smoked per day, or in the intake of alcohol (model 4) during the 11-year follow-up, smoking at baseline was associated with a graded increase in the risk of hypertension during the 11-year follow-up. The increase in risk of smoking in model 4 compared with model 3 was a result of adjustment for the change in smoking, alcohol intake, and waist circumference. Adjustment for the changes in waist girth, smoking, or alcohol intake during the 4-year period gave essentially identical results as in model 4. Abdominal Obesity at Baseline and Hypertension Waist girth at baseline more than doubled the likelihood of hypertension in age-adjusted analyses (Table 2). Further adjustment for baseline systolic blood pressure and lifestyle factors (model 2) attenuated the association, which was mainly attributable to inclusion of CRP and baseline systolic blood pressure into the model. Additional adjustment for variables related to the metabolic syndrome (model 3) further attenuated the association such that it was no longer significant. Adjustment for the changes in waist girth, smoking, or alcohol intake during the 4-year period gave essentially identical results as adjustment for changes during the 11-year follow-up. Alcohol Intake at Baseline and Hypertension Men reporting consumption of 7 drinks per week were 1.5 more likely than nondrinkers to develop hypertension during the 11-year follow-up in age-adjusted analyses, but the association was not significant (Table 2). The ORs attenuated even further in multivariate analyses. Incident Hypertension and Changes in Smoking, Alcohol Intake, and Waist Girth Of the changes in smoking, alcohol intake, and leisure-time physical activity, only the changes in smoking and alcohol intake were associated with incident hypertension. When adjusting for only age and baseline smoking, the change in the number of cigarettes smoked was not associated with development of hypertension (Table 3). However, with further multivariate adjustment, the association strengthened, which was attributable mainly to the inclusion of baseline waist girth and HDL cholesterol levels in model 3 and to the inclusion of the change in waist girth to model 4. The association of the change in number of cigarettes smoked per
6 Niskanen et al CRP, Smoking, and Hypertension 863 TABLE 3. ORs for Developing Hypertension According to the Change in Smoking, Alcohol Intake, and Waist Girth During the 11-Year Follow-Up Predictive Variable Model 1 Model 2 Model 3 Model 4 Change in smoking (for an decrease of 10 cigarettes per day)* 4-year change 0.97 ( ) 0.90 ( ) 0.65 ( ) 0.58 ( ) 11-year change 0.88 ( ) 0.86 ( ) 0.56 ( ) 0.51 ( ) Change in alcohol intake (for an increase of 84 g ethanol per week, equivalent to 1 drink per day) 4-year change 1.34 ( ) 1.37 ( ) 1.40 ( ) 1.34 ( ) 11-year change 1.13 ( ) 1.16 ( ) 1.18 ( ) 1.14 ( ) Change in waist (for a 5-cm increase during follow-up) 4-year change 1.38 ( ) 1.55 ( ) 1.57 ( ) 1.59 ( ) 11-year change 1.32 ( ) 1.27 ( ) 1.27 ( ) 1.31 ( ) *Model 1, Adjusted for age and baseline smoking (none, 1 19, and 20 cigarettes per day); model 2, adjusted for age, baseline CRP categories, smoking, alcohol intake (abstinent, 1 83 g, and 84 g ethanol per week), adult socioeconomic status, leisure-time physical activity, presence of cardiovascular disease, intake of energy-adjusted dietary factors (dietary intake of saturated fat, sodium, potassium, and fruits and vegetables), and baseline systolic blood pressure; model 3, adjusted for variables in model 2 and waist girth ( 82.5 cm, cm, and 88.5 cm), and concentrations of insulin, glucose, and triglycerides; model 4, adjusted for variables in model 3 and changes in waist girth and alcohol intake (g/day) during the 11-year period. Models as above, except that alcohol categories were used as a covariate in place of smoking in model 1, and the change in smoking (cigarettes per day) during follow-up was used as a covariate in place of change in alcohol intake in model 4. Models as above, except that baseline waist categories were used as a covariate in place of baseline smoking in model 1, baseline waist circumference was also included in place of CRP categories in model 2, and adjustment for changes in alcohol intake and smoking was made in model 4. day during the 11-year follow-up with incident hypertension was significant also in analyses confined to smokers (eg, in models 2 to 4; OR, 0.42 to 0.56 for a 10-cigarette decrease; P to 0.006). The relevance of taking into account the change in waist girth in the association of the change in smoking with development of hypertension is also illustrated by the increase in waist circumference with smoking cessation. The waist girth of nonsmokers who remained nonsmokers increased 7.3 cm (95% confidence interval [CI], 6.6 to 8.1), and that of smokers at baseline who remained smokers increased 7.0 cm (95% CI, 5.7 to 8.3) during the 11-year follow-up. In contrast, the waist girth of men who quit during the follow-up increased by 10.4 cm (95% CI, 8.7 to 12.2; P for the difference between groups after adjustment for age and baseline waist girth). An increase in alcohol intake also increased the risk of hypertension during the 11-year follow-up. Of the changes during follow-up in the metabolic variables shown in model 3, only the change in waist girth was associated with development of hypertension (Table 3). Multivariate adjustment had little effect on the association. Discussion This study extends the findings of Women s Health Study 4 of chronic low-grade inflammation as a predictor of hypertension in men. Moreover, this association is not explained by various lifestyle factors or features of the metabolic syndrome. Although hypertension is another member of a long list of disorders preceded by low-grade inflammation, the mechanisms of the mediating factors remain elusive. Based on the results of this study, inflammation as measured by highly sensitive CRP concentrations is clearly more than a marker of abdominal obesity or the metabolic syndrome and is not explained by smoking or presence of cardiovascular disease. There could well be an underlying genetic propensity, although little data currently exist to support this conviction. On the other hand, low-grade inflammation as measured by CRP levels could still be a marker of highly active cytokineproducing adipose tissue infiltrated by macrophages and leading to complement activation and release of vasoactive cytokines and subsequent endothelial dysfunction; 8,21 and any increase in the amount of fat tissue, especially in the abdominal area, could lead to more active function and development of hypertension. This mechanism is unlikely to explain a major part of the association of CRP levels with incident hypertension because adjustment for waist girth and other variables related to the metabolic syndrome only slightly attenuated the association. Elevated CRP concentrations may also be secondary to artery wall thickening and atherosclerotic burden, but adjustment for carotid intima thickness did not alter the predictive value of CRP. CRP itself may cause endothelial dysfunction. 22 Furthermore, CRP may upregulate angiotensin type 1 receptors, leading to proliferation of vascular smooth muscle cells 23 and subsequently to hypertension. In this study, the predictive role of smoking with development of hypertension was somewhat surprising. Middle-aged men who decreased the number of cigarettes smoked daily by 10 were not less likely to develop hypertension in ageadjusted analyses. However, when taking into account waist at baseline and the increase in waist girth in addition to other variables, decreasing the number of cigarettes smoked by 10 halved their adjusted risk of hypertension. Thus, even smok-
7 864 Hypertension December 2004 ing cessation did not seem to protect from hypertension, most likely because of the associated increase in abdominal obesity. There are previous reports suggesting that smoking or smoking cessation may indeed be a harbinger for development of hypertension, but generally, smoking has not been considered a causative factor of hypertension. One of the mechanisms may be smoking-induced renal damage. 28 Alcohol intake was weakly associated with development of hypertension, and after multivariate adjustment, the connection was abolished. On the other hand, an increase in alcohol intake during the follow-up was clearly associated with a higher incidence of hypertension. The overall weak association of alcohol intake with incident hypertension may be attributable to the difficulty in the reliable recording of alcohol intake. The strengths of this study are the population-based prospective design, high participation rate, detailed assessment of variables related to lifestyle, and the metabolic syndrome and use of a uniform and constant definition of hypertension with careful measurement of blood pressure according to a standard protocol. Importantly, the changes of major variables related to lifestyle and the metabolic syndrome during follow-up were determined. The limitations are that of the various inflammatory markers, only a single baseline measurement of CRP was taken into account. However, this, if anything, leads to conservative estimate of the association in question. The study was performed in middle-aged white men, and generalization to other groups should be viewed with caution. Perspectives We have demonstrated that hypertension is preceded by low-grade chronic inflammation as assessed by CRP in middle-aged white men. This connection was not explained by smoking, baseline systolic blood pressure, or features of metabolic syndrome. Furthermore, smoking may be a risk factor for hypertension. Although stopping smoking is extremely beneficial with respect to cardiovascular risk and other health outcomes, the subsequent weight gain and increase in waist girth associated with smoking cessation may offset the decrease in risk of hypertension that one may otherwise expect. Therefore, efforts to curtail smoking should also take more seriously into account the consequences of the subsequent weight gain because the early prevention of abdominal obesity may be easier than later attempts at weight loss and control of hypertension. This study illustrates that multiple pathways seem to lead to hypertension independently of inflammation, including an increase in waist girth and smoking, even when the relevant changes during the follow-up are taken into account. Acknowledgments The Kuopio Ischemic Heart Disease Risk Factor Study was supported by grants from the Academy of Finland (grants 41471, 45155, , and ), the Ministry of Education of Finland (grants 167/722/96, 157/722/97, and 156/722/98), and the National Heart, Lung, and Blood Institute of the United States (grant HL44199). We thank the staff of the Research Institute of Public Health, University of Kuopio, and Kuopio Research Institute of Exercise Medicine for data collection in the Kuopio Ischemic Heart Disease Risk Factor Study. References 1. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98: Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, IL 6, and risk of developing type 2 diabetes mellitus. JAmMed Assoc. 2001;286: Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004;47: Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAmMed Assoc. 2003;290: Grundy SM. Inflammation, hypertension, and the metabolic syndrome. J Am Med Assoc. 2003;290: Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med. 2003;138: Crook MA, Scott DA, Stapleton JA, Palmer RM, Wilson RF, Sutherland G. Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation. Eur J Clin Invest. 2000;30: Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112: Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Campbell LV. Moderate alcohol consumption, dietary fat composition, and abdominal obesity in women: evidence for gene-environment interaction. J Clin Endocrinol Metab. 2003;88: Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res. 1988;20: Joint National Committee. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157: World Health Organization-International Society of Hypertension World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17: Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15: Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen T-P, Salonen R, Rauramaa R, Salonen JT. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol. 2003;149: Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107: Lynch JW, Kaplan GA, Cohen RD, Kauhanen J, Wilson TW, Smith NL, Salonen JT. Childhood and adult socioeconomic status as predictors of mortality in Finland. Lancet. 1994;343: Laaksonen DE, Lakka HM, Salonen JT, Niskanen LK, Rauramaa R, Lakka TA. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care. 2002;25: Laaksonen DE, Nyyssonen K, Niskanen L, Rissanen TH, Salonen JT. Dietary and serum linoleic and polyunsaturated fatty acids predict cardiovascular mortality in middle-aged men. Arch Intern Med. In press. 19. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993;87:II56 II Lean ME, Han TS, Seidell JC. Impairment of health and quality of life in people with large waist circumference. Lancet. 1998;351:
8 Niskanen et al CRP, Smoking, and Hypertension Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003;112: Verma S, Yeh ET. C-reactive protein and atherothrombosis beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol. 2003;285:R1253 R Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, Li RK, Mickle DA, Verma S. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 2003;107: Rywik SL, Williams OD, Pajak A, Broda G, Davis CE, Kawalec E, Manolio TA, Piotrowski W, Hutchinson R. Incidence and correlates of hypertension in the Atherosclerosis Risk in Communities (ARIC) Study and the Monitoring Trends and Determinants of Cardiovascular Disease (POL-MONICA) Project. J Hypertens. 2000;18: Lee DH, Ha MH, Kim JR, Jacobs DR Jr. Effects of smoking cessation on changes in blood pressure and incidence of hypertension: a 4-year follow-up study. Hypertension. 2001;37: Janzon E, Hedblad B, Berglund G, Engstrom G. Changes in blood pressure and body weight following smoking cessation in women. J Intern Med. 2004;255: Schut AF, Sayed-Tabatabaei FA, Witteman JC, Avella AM, Vergeer JM, Pols HA, Hofman A, Deinum J, van Duijn CM. Smoking-dependent effects of the angiotensin-converting enzyme gene insertion/deletion polymorphism on blood pressure. J Hypertens. 2004;22: Orth SR. Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function. J Am Soc Nephrol. 2004;15(suppl 1):S58 S National Cholesterol Education Program. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc. 2001;285: Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J Am Med Assoc. 2002; 288:
ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationMagnesium intake and serum C-reactive protein levels in children
Magnesium Research 2007; 20 (1): 32-6 ORIGINAL ARTICLE Magnesium intake and serum C-reactive protein levels in children Dana E. King, Arch G. Mainous III, Mark E. Geesey, Tina Ellis Department of Family
More informationMetabolic Syndrome and the Risk of Stroke in Middle-Aged Men
Metabolic Syndrome and the Risk of Stroke in Middle-Aged Men Sudhir Kurl, MD; Jari A. Laukkanen, MD; Leo Niskanen, MD, PhD; David Laaksonen, MD, PhD; Juhani Sivenius, MD, PhD; Kristiina Nyyssönen, PhD;
More informationTHE METABOLIC SYNDROME, A
ORIGINAL CONTRIBUTION The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men Hanna-Maaria Lakka, MD, PhD David E. Laaksonen, MD, MPH Timo A. Lakka, MD, PhD Leo K. Niskanen,
More informationC-reactive protein and the risk of developing type 2 diabetes in Aboriginal Australians
C-reactive protein and the risk of developing type 2 diabetes in Aboriginal Australians Zhiqiang Wang and Wendy E. Hoy Centre for Chronic Disease, School of Medicine, The University of Queensland, Level
More informationJournal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043
More informationGlycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men:
Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study Jaakko Mursu, Jyrki K. Virtanen, Tiina H. Rissanen,
More informationAssociation between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,
More informationNon alcoholic fatty liver disease and atherosclerosis Raul Santos, MD
Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD Sao Paulo Medical School Hospital Sao Paulo, Brazil Disclosure Honoraria received for consult and/or speaker : Astra Zeneca, Amgen,
More informationAssociations between Metabolic Syndrome and Inadequate Sleep Duration and Skipping Breakfast
http://dx.doi.org/.482/kjfm.25.36.6.273 Korean J Fam Med 25;36:273-277 eissn: 292-675 Original Article Associations between Metabolic Syndrome and Inadequate Sleep Duration and Skipping Breakfast Nak-Hyun
More informationResearch Article Comparison of Different Anthropometric Measurements and Inflammatory Biomarkers
International Inflammation Volume 2012, Article ID 124693, 5 pages doi:10.1155/2012/124693 Research Article Comparison of Different Anthropometric Measurements and Inflammatory Biomarkers Yaron Arbel,
More information300 Biomed Environ Sci, 2018; 31(4):
300 Biomed Environ Sci, 2018; 31(4): 300-305 Letter to the Editor Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of
More informationA PROSPECTIVE STUDY OF CIGARETTE SMOKING AND RISK OF INCIDENT HYPERTENSION IN WOMEN
A PROSPECTIVE STUDY OF CIGARETTE SMOKING AND RISK OF INCIDENT HYPERTENSION IN WOMEN Thomas S. Bowman, MD, MPH, J. Michael Gaziano, MD, MPH, Julie E. Buring ScD and Howard D. Sesso ScD, MPH From the Veterans
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationAndrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University
CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients
More informationCardiovascular Disease Risk Factors:
Cardiovascular Disease Risk Factors: Risk factors are traits or habits that increase a person's chances of having cardiovascular disease. Some risk factors can be changed. These risk factors are high blood
More informationClinical Recommendations: Patients with Periodontitis
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;
More informationClinical Practice Guideline
Clinical Practice Guideline Secondary Prevention for Patients with Coronary and Other Vascular Disease Since the 2001 update of the American Heart Association (AHA)/American College of Cardiology (ACC)
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationThe Adult Treatment Panel (ATP) III of the National
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study Naveed Sattar, MD; Allan Gaw, MD; Olga Scherbakova,
More informationA Prospective Study of Cigarette Smoking and Risk of Incident Hypertension in Women
Journal of the American College of Cardiology Vol. 50, No. 21, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.08.017
More informationEFFECT OF SMOKING ON BODY MASS INDEX: A COMMUNITY-BASED STUDY
ORIGINAL ARTICLE. EFFECT OF SMOKING ON BODY MASS INDEX: A COMMUNITY-BASED STUDY Pragti Chhabra 1, Sunil K Chhabra 2 1 Professor, Department of Community Medicine, University College of Medical Sciences,
More informationPatients with the metabolic syndrome are at increased risk
Clinical Investigation and Reports C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events An 8-Year Follow-Up of 14 719 Initially Healthy American Women Paul M Ridker, MD;
More informationTable S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).
Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationMETABOLIC SYNDROME IN TYPE-2 DIABETES MELLITUS
METABOLIC SYNDROME IN TYPE-2 DIABETES MELLITUS S.M. Sohail Ashraf 1, Faisal Ziauddin 2, Umar Jahangeer 3 ABSTRACT Objective: To find out the prevalence of metabolic syndrome in type-2 Diabetes Mellitus
More informationSupplemental table 1. Dietary sources of protein among 2441 men from the Kuopio Ischaemic Heart Disease Risk Factor Study MEAT DAIRY OTHER ANIMAL
ONLINE DATA SUPPLEMENT 1 SUPPLEMENTAL MATERIAL Pork Bacon Turkey Kidney Cream Cottage cheese Mutton and lamb Game (elk, reindeer) Supplemental table 1. Dietary sources of protein among 2441 men from the
More informationprogramme. The DE-PLAN follow up.
What are the long term results and determinants of outcomes in primary health care diabetes prevention programme. The DE-PLAN follow up. Aleksandra Gilis-Januszewska, Noël C Barengo, Jaana Lindström, Ewa
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationThe Framingham Risk Score (FRS) is widely recommended
C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany Wolfgang Koenig, MD; Hannelore
More informationModerate alcohol consumption is associated with decreased
Alcohol Consumption and Plasma Concentration of C-Reactive Protein Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Moderate alcohol intake has been associated with
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationLEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME
LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME Diana A. Chirinos, Ronald Goldberg, Elias Querales-Mago, Miriam Gutt, Judith R. McCalla, Marc Gellman and Neil Schneiderman
More informationOf the 1.5 million heart attacks
CARDIOLOGY PATIENT PAGE CARDIOLOGY PATIENT PAGE C-Reactive Protein A Simple Test to Help Predict Risk of Heart Attack and Stroke Paul M Ridker, MD, MPH Of the 1.5 million heart attacks and 600 000 strokes
More informationIs Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea
Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea Hyuncheol Bryant Kim 1, Suejin A. Lee 1, and Wilfredo Lim 2 1 Cornell University
More informationScreening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016
Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October
More informationSession 21: Heart Health
Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk
More informationSupplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and
1 Supplementary Online Content 2 3 4 5 6 Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardiometabolic risk factor management on sympton burden and severity in patients with atrial
More informationMOLINA HEALTHCARE OF CALIFORNIA
MOLINA HEALTHCARE OF CALIFORNIA HIGH BLOOD CHOLESTEROL IN ADULTS GUIDELINE Molina Healthcare of California has adopted the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel
More informationPlasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationChapter 18. Diet and Health
Chapter 18 Diet and Health Risk Factors and Chronic Diseases Interrelationships among Chronic Diseases Chronic Disease Heart Disease and Stroke Hypertension Cancer Diabetes The Formation of Plaques in
More informationSociety for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA
Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA John M. Violanti, PhD* a ; LuendaE. Charles, PhD, MPH b ; JaK. Gu, MSPH b ; Cecil M. Burchfiel, PhD, MPH b ; Michael E. Andrew, PhD
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More informationBariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes
The new england journal of medicine original article Bariatric Surgery versus Intensive Medical for Diabetes 3-Year Outcomes Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D.,
More informationFish consumption in relation to cardiovascular risk factors
Fish consumption in relation to cardiovascular risk factors Anu Turunen 1, Liisa Suominen-Taipale 1, Satu Männistö 2, Hannu Kiviranta 1, Antti Jula 3, Jukka Marniemi 3 & Pia K. Verkasalo 1 National Public
More informationSerum Concentration of High-sensitivity CRP in Metabolic Syndrome A Case-control Study
Serum Concentration of High-sensitivity CRP in Metabolic Syndrome A Case-control Study Faisal Gh. Al-Rubaye (PhD; MSc)*, Hashim M. Hashim** Yahya Y Z. Farid (PhD)*, Kadhum Jumah (BSc)* Abstract Background:
More informationIs socioeconomic position related to the prevalence of metabolic syndrome? Influence of
Is socioeconomic position related to the prevalence of metabolic syndrome? Influence of social class across the life-course in a population-based study of older men Sheena E Ramsay, MPH 1, Peter H Whincup,
More informationInflammation in Renal Disease
Inflammation in Renal Disease Donald G. Vidt, MD Inflammation is a component of the major modifiable risk factors in renal disease. Elevated high-sensitivity C-reactive protein (hs-crp) levels have been
More informationAssessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution
CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised
More informationOriginal Research Article
A STUDY TO ESTIMATE SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY MEASURING THE CAROTID INTIMAL MEDIAL THICKNESS Natarajan Kandasamy 1, Rajan Ganesan 2, Thilakavathi Rajendiran
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationCardiorespiratory Fitness is Strongly Related to the Metabolic Syndrome in Adolescents. Queen s University Kingston, Ontario, Canada
Diabetes Care In Press, published online May 29, 2007 Cardiorespiratory Fitness is Strongly Related to the Metabolic Syndrome in Adolescents Received for publication 16 April 2007 and accepted in revised
More informationThere is a growing body of evidence
Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Risk of Type 2 Diabetes Attributable to C-Reactive Protein and Other Risk Factors ABBAS DEHGHAN, MD, DSC 1 MANDY VAN HOEK, MD 2 ERIC J.G.
More informationDietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women
07/14/2010 Dietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women First Author: Wang Short Title: Dietary Fatty Acids and Hypertension Risk in Women Lu Wang, MD, PhD, 1 JoAnn E.
More informationAssociation of Cardiovascular Risk Factors in Hypertensive Subjects with Metabolic Syndrome De ned by Three Different De nitions
ORIGINAL ARTICLE J Nepal Med Assoc 2011;51(184):157-63 Association of Cardiovascular Risk Factors in Hypertensive Subjects with Metabolic Syndrome De ned by Three Different De nitions Shrestha R 1, Jha
More informationSupplementary Online Content
Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines
More informationPrimary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group
Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to
More informationThe Impact Of Adiposity And Insulin Resistance On Endothelial Function In Middle-Aged Subjects
ISPUB.COM The Internet Journal of Cardiovascular Research Volume 1 Number 1 The Impact Of Adiposity And Insulin Resistance On Endothelial Function In Middle-Aged Subjects L Zhu, K Liu Citation L Zhu, K
More informationARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority:
ARIC Manuscript Proposal #1233 PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: 1.a. Full Title: Subclinical atherosclerosis precedes type 2 diabetes in the ARIC study cohort
More informationASSeSSing the risk of fatal cardiovascular disease
ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril
More information902 Biomed Environ Sci, 2014; 27(11):
902 Biomed Environ Sci, 2014; 27(11): 902-906 Letter to the Editor Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION
ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION Jung-Sun Kim a and Sungha Park a,b, a Division of Cardiology, b Cardiovascular Genome Center, Yonsei Cardiovascular Center,
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationNormal Fasting Plasma Glucose and Risk of Type 2 Diabetes Diagnosis
CLINICAL RESEARCH STUDY Normal Fasting Plasma Glucose and Risk of Type 2 Diabetes Diagnosis Gregory A. Nichols, PhD, Teresa A. Hillier, MD, MS, Jonathan B. Brown, PhD, MPP Center for Health Research, Kaiser
More information2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature
More informationCardiovascular Disease
Cardiovascular Disease Controlling your risk factors WE RECOMMEND THAT YOU Monitor your blood pressure on a regular basis If you have high blood pressure, reduce your intake of salt, tea and coffee Drink
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationDyslipidemia, hypertension, smoking, and diabetes are
Inflammation-Sensitive Plasma Proteins and Incidence of Myocardial Infarction in Men With Low Cardiovascular Risk Gunnar Engström, Lars Stavenow, Bo Hedblad, Peter Lind, Patrik Tydén, Lars Janzon, Folke
More informationTerm-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY
MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple
More informationImpact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography
Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Cardiovascular Division, Faculty of Medicine, University of Tsukuba Akira
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More information(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects
Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values
More informationEpidemiology and Prevention
Epidemiology and Prevention Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age The Avon Longitudinal Study of Parents and
More informationCardiorespiratory Fitness as a Feature of Metabolic Syndrome in Older Men and Women. The Dose-Responses to Exercise Training Study (DR s EXTRA)
Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Cardiorespiratory Fitness as a Feature of Metabolic Syndrome in Older Men and Women The Dose-Responses to Exercise Training Study (DR s EXTRA)
More informationConsideration of Anthropometric Measures in Cancer. S. Lani Park April 24, 2009
Consideration of Anthropometric Measures in Cancer S. Lani Park April 24, 2009 Presentation outline Background in anthropometric measures in cancer Examples of anthropometric measures and investigating
More informationAssociation between C-reactive protein and Incidence of Type-2 Diabetes in a Japanese Worksite-based Cohort
Association between C-reactive protein and Incidence of Type-2 Diabetes in a Japanese Worksite-based Cohort Chaochen Wang 1, Hiroshi Yatsuya 1, Koji Tamakoshi 1, Hideaki Toyoshima 2, Yuanying Li 3,Kentaro
More informationRisk Factor Analysis for Development of Asymptomatic Carotid Stenosis in Koreans
J Korean Med Sci 2006; 21: 15-9 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences Risk Factor Analysis for Development of Asymptomatic Carotid Stenosis in Koreans Many risk factors for atherosclerosis
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationAssessing Cardiovascular Disease Risk with HS-C-reactive. California Technology Assessment Forum
TITLE: Assessing Cardiovascular Disease Risk with HS-C-reactive Protein AUTHOR: Judith Walsh, M.D., MPH Professor of Medicine Division of General Internal Medicine Department of Medicine University of
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationThe investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India
eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,
More informationVal-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions in hs-crp
Página 1 de 5 Return to Medscape coverage of: American Society of Hypertension 21st Annual Scientific Meeting and Exposition Val-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions
More informationAdherence to a healthy diet in relation to cardiovascular incidence and risk markers: evidence from the Caerphilly Prospective Study
DOI 10.1007/s00394-017-1408-0 ORIGINAL CONTRIBUTION Adherence to a healthy diet in relation to cardiovascular incidence and risk markers: evidence from the Caerphilly Prospective Study Elly Mertens 1,2
More informationCoronary Artery Disease Clinical Practice Guidelines
Coronary Artery Disease Clinical Practice Guidelines Guidelines are systematically developed statements to assist patients and providers in choosing appropriate healthcare for specific clinical conditions.
More informationImpact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients
2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type
More informationHealth Score SM Member Guide
Health Score SM Member Guide Health Score Your Health Score is a unique, scientifically based assessment of seven critical health indicators gathered during your health screening. This number is where
More informationCombined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women
European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular
More informationUnderstanding Risk Factors for Stroke
MINTO PREVENTION & REHABILITATION CENTRE CENTRE DE PREVENTION ET DE READAPTATION MINTO Understanding Risk Factors for Stroke About This Kit Risk factors have been identified that can predict who is most
More informationObesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians
Obesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians Anoop Misra Developing countries, particularly South Asian countries, are witnessing a rapid increase in type 2 diabetes
More information1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?
1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationFasting Glucose, Obesity, and Metabolic Syndrome as Predictors of Type 2 Diabetes: The Cooper Center Longitudinal Study
Fasting Glucose, Obesity, and Metabolic Syndrome as Predictors of Type 2 Diabetes: The Cooper Center Longitudinal Study Laura F. DeFina, MD,* Gloria Lena Vega, PhD,Þ David Leonard, PhD,Þ and Scott M. Grundy,
More informationCHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION
CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION 3.1 BACKGROUND Diabetes mellitus (DM) and impaired glucose tolerance (IGT) have reached epidemic proportions
More informationSupplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationChronic kidney disease (CKD) has received
Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:
More information